Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RPL554 vs Salbutamol in Chronic Asthma
NCT02427165Phase 2Completed
- Sponsor
- Verona Pharma
- Start
- Apr 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ensifentrine in asthma, sponsored by Verona Pharma. Started Apr 2015; status: completed.
02
Drugs
ensifentrine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02427165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427165.